アムロジピン-アトルバスタチンの世界市場インサイト・予測(~2025年)

QYResearchが発行した調査報告書(QYR20FB05469)
◆英語タイトル:Global Amlodipine-Atorvastatin Market Insights, Forecast to 2025
◆商品コード:QYR20FB05469
◆発行会社(リサーチ会社):QYResearch
◆発行日:2019年11月13日(※2024年版があります。お問い合わせください。)
◆ページ数:112
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※本調査レポートでは、世界のアムロジピン-アトルバスタチン市場について調査・分析し、以下の構成でお届け致します。アムロジピン-アトルバスタチンの種類別には、2.5mg/40mgタブレット、5mg/10mgタブレット、5mg/20mgタブレット、5mg/40mgタブレット、5mg/80mgタブレット、10mg/10mgタブレット、10mg/20mgタブレット、10mg/40mgタブレット、10mg/80mgタブレットに、用途別には、病院、ドラッグストアに、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。

・調査販売
・エグゼクティブ・サマリー
・企業別アムロジピン-アトルバスタチン売上データ
・地域別アムロジピン-アトルバスタチン市場規模:北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他
・種類別アムロジピン-アトルバスタチン市場規模:2.5mg/40mgタブレット、5mg/10mgタブレット、5mg/20mgタブレット、5mg/40mgタブレット、5mg/80mgタブレット、10mg/10mgタブレット、10mg/20mgタブレット、10mg/40mgタブレット、10mg/80mgタブレット
・用途別アムロジピン-アトルバスタチン市場規模:病院、ドラッグストア
・主要メーカーの企業情報:Pfizer、Apotex、Mylan、Dr. Reddys Laboratories
・アムロジピン-アトルバスタチンの市場規模予測
・バリューチェーン及び販売チャネル分析
・市場機会・課題・リスク・影響因子分析
...
【レポートの概要】

Amlodipine-Atorvastatin Drug contains two active ingredients: amlodipine and atorvastatin. Amlodipine belongs to a group of medications known as calcium channel blockers. It reduces blood pressure and the workload on the heart by relaxing the walls of the blood vessels. It is used to lower blood pressure and to treat angina (chest pain). Atorvastatin belongs to a group of medications known as HMG CoA reductase inhibitors (also known as “statins”). It is used in combination with diet and exercise to treat high cholesterol. It works by blocking an enzyme that is needed to make cholesterol in the body.The global Amlodipine-Atorvastatin market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Amlodipine-Atorvastatin market based on company, product type, end user and key regions.

This report studies the global market size of Amlodipine-Atorvastatin in key regions like North America, Europe, China and Japan, focuses on the consumption of Amlodipine-Atorvastatin in these regions.
This research report categorizes the global Amlodipine-Atorvastatin market by top players/brands, region, type and end user. This report also studies the global Amlodipine-Atorvastatin market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Pfizer
Apotex
Mylan
Dr. Reddys Laboratories

Amlodipine-Atorvastatin market size by Type
2.5mg/40mg Tablet
5mg/10mg Tablet
5mg/20mg Tablet
5mg/40mg Tablet
5mg/80mg Tablet
10mg/10mg Tablet
10mg/20mg Tablet
10mg/40mg Tablet
10mg/80mg Tablet

Amlodipine-Atorvastatin market size by Applications
Hospital
Drug store

Market size by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Amlodipine-Atorvastatin market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Amlodipine-Atorvastatin market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Amlodipine-Atorvastatin companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Amlodipine-Atorvastatin submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Amlodipine-Atorvastatin are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Amlodipine-Atorvastatin market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Study Coverage
1.1 Amlodipine-Atorvastatin Product Introduction
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Amlodipine-Atorvastatin Market Size Growth Rate by Type
1.4.2 2.5mg/40mg Tablet
1.4.3 5mg/10mg Tablet
1.4.4 5mg/20mg Tablet
1.4.5 5mg/40mg Tablet
1.4.6 5mg/80mg Tablet
1.4.7 10mg/10mg Tablet
1.4.8 10mg/20mg Tablet
1.4.9 10mg/40mg Tablet
1.4.10 10mg/80mg Tablet
1.5 Market by Application
1.5.1 Global Amlodipine-Atorvastatin Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Drug store
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Amlodipine-Atorvastatin Market Size
2.1.1 Global Amlodipine-Atorvastatin Revenue 2014-2025
2.1.2 Global Amlodipine-Atorvastatin Sales 2014-2025
2.2 Amlodipine-Atorvastatin Growth Rate by Regions
2.2.1 Global Amlodipine-Atorvastatin Sales by Regions
2.2.2 Global Amlodipine-Atorvastatin Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Amlodipine-Atorvastatin Sales by Manufacturers
3.1.1 Amlodipine-Atorvastatin Sales by Manufacturers
3.1.2 Amlodipine-Atorvastatin Sales Market Share by Manufacturers
3.2 Amlodipine-Atorvastatin Revenue by Manufacturers
3.2.1 Amlodipine-Atorvastatin Revenue by Manufacturers (2014-2019)
3.2.2 Amlodipine-Atorvastatin Revenue Share by Manufacturers (2014-2019)
3.3 Amlodipine-Atorvastatin Price by Manufacturers
3.4 Amlodipine-Atorvastatin Manufacturing Base Distribution, Product Types
3.4.1 Amlodipine-Atorvastatin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Amlodipine-Atorvastatin Product Type
3.4.3 Date of International Manufacturers Enter into Amlodipine-Atorvastatin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Amlodipine-Atorvastatin Sales by Type
4.2 Global Amlodipine-Atorvastatin Revenue by Type
4.3 Amlodipine-Atorvastatin Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Amlodipine-Atorvastatin Breakdown Data by Application

6 North America
6.1 North America Amlodipine-Atorvastatin by Country
6.1.1 North America Amlodipine-Atorvastatin Sales by Country
6.1.2 North America Amlodipine-Atorvastatin Revenue by Country
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Amlodipine-Atorvastatin by Type
6.3 North America Amlodipine-Atorvastatin by Application

7 Europe
7.1 Europe Amlodipine-Atorvastatin by Country
7.1.1 Europe Amlodipine-Atorvastatin Sales by Country
7.1.2 Europe Amlodipine-Atorvastatin Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Amlodipine-Atorvastatin by Type
7.3 Europe Amlodipine-Atorvastatin by Application

8 Asia Pacific
8.1 Asia Pacific Amlodipine-Atorvastatin by Region
8.1.1 Asia Pacific Amlodipine-Atorvastatin Sales by Region
8.1.2 Asia Pacific Amlodipine-Atorvastatin Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Thailand
8.1.10 Malaysia
8.1.11 Philippines
8.1.12 Vietnam
8.2 Asia Pacific Amlodipine-Atorvastatin by Type
8.3 Asia Pacific Amlodipine-Atorvastatin by Application

9 Central & South America
9.1 Central & South America Amlodipine-Atorvastatin by Country
9.1.1 Central & South America Amlodipine-Atorvastatin Sales by Country
9.1.2 Central & South America Amlodipine-Atorvastatin Revenue by Country
9.1.3 Brazil
9.2 Central & South America Amlodipine-Atorvastatin by Type
9.3 Central & South America Amlodipine-Atorvastatin by Application

10 Middle East and Africa
10.1 Middle East and Africa Amlodipine-Atorvastatin by Country
10.1.1 Middle East and Africa Amlodipine-Atorvastatin Sales by Country
10.1.2 Middle East and Africa Amlodipine-Atorvastatin Revenue by Country
10.1.3 Turkey
10.1.4 GCC Countries
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Amlodipine-Atorvastatin by Type
10.3 Middle East and Africa Amlodipine-Atorvastatin by Application

11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Company Business Overview
11.1.3 Pfizer Amlodipine-Atorvastatin Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Pfizer Amlodipine-Atorvastatin Products Offered
11.1.5 Pfizer Recent Development
11.2 Apotex
11.2.1 Apotex Company Details
11.2.2 Company Business Overview
11.2.3 Apotex Amlodipine-Atorvastatin Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Apotex Amlodipine-Atorvastatin Products Offered
11.2.5 Apotex Recent Development
11.3 Mylan
11.3.1 Mylan Company Details
11.3.2 Company Business Overview
11.3.3 Mylan Amlodipine-Atorvastatin Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Mylan Amlodipine-Atorvastatin Products Offered
11.3.5 Mylan Recent Development
11.4 Dr. Reddys Laboratories
11.4.1 Dr. Reddys Laboratories Company Details
11.4.2 Company Business Overview
11.4.3 Dr. Reddys Laboratories Amlodipine-Atorvastatin Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Dr. Reddys Laboratories Amlodipine-Atorvastatin Products Offered
11.4.5 Dr. Reddys Laboratories Recent Development

12 Future Forecast
12.1 Amlodipine-Atorvastatin Market Forecast by Regions
12.1.1 Global Amlodipine-Atorvastatin Sales Forecast by Regions 2019-2025
12.1.2 Global Amlodipine-Atorvastatin Revenue Forecast by Regions 2019-2025
12.2 Amlodipine-Atorvastatin Market Forecast by Type
12.2.1 Global Amlodipine-Atorvastatin Sales Forecast by Type 2019-2025
12.2.2 Global Amlodipine-Atorvastatin Revenue Forecast by Type 2019-2025
12.3 Amlodipine-Atorvastatin Market Forecast by Application
12.4 North America Amlodipine-Atorvastatin Forecast
12.5 Europe Amlodipine-Atorvastatin Forecast
12.6 Asia Pacific Amlodipine-Atorvastatin Forecast
12.7 Central & South America Amlodipine-Atorvastatin Forecast
12.8 Middle East and Africa Amlodipine-Atorvastatin Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Amlodipine-Atorvastatin Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

...

【掲載企業】

Pfizer、Apotex、Mylan、Dr. Reddys Laboratories

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ アムロジピン-アトルバスタチンの世界市場インサイト・予測(~2025年)(Global Amlodipine-Atorvastatin Market Insights, Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。